Kalaris Therapeutics
NMQ:KLRS · US4829291065
BiotechnologySmall
360° View
36
Value1
Growth93
Safety73
Combined63
Sentiment23
Profile
CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Websitekalaristx.com
ISINUS4829291065
Last UpdateApr 2, 2026
Index & Theme
Ophthalmology
Description
Analysis
Kalaris Therapeutics's 360° View rank of 36 places it below its peer average — better than 36% of its true peers.
360° rank · history
1007550250
36
2026
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.
Similar Stocks
The companies this stock is ranked against.
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100